Ignite Creation Date:
2025-12-24 @ 10:41 PM
Ignite Modification Date:
2026-02-02 @ 5:05 AM
Study NCT ID:
NCT04552535
Status:
COMPLETED
Last Update Posted:
2022-01-11
First Post:
2020-09-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study in the United States Using Electronic Medical Records (EMR) to Assess Effectiveness of Afatinib (Gilotrif) Following Pembrolizumab and Chemotherapy in the Treatment of Metastatic Squamous Cell Carcinoma of the Lung
Sponsor:
Boehringer Ingelheim
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Squamous Non-small Cell Lung Cancer | View |
Keywords: